GB2106388B - Antiparkinsonian agent - Google Patents

Antiparkinsonian agent

Info

Publication number
GB2106388B
GB2106388B GB08227076A GB8227076A GB2106388B GB 2106388 B GB2106388 B GB 2106388B GB 08227076 A GB08227076 A GB 08227076A GB 8227076 A GB8227076 A GB 8227076A GB 2106388 B GB2106388 B GB 2106388B
Authority
GB
United Kingdom
Prior art keywords
antiparkinsonian agent
antiparkinsonian
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08227076A
Other languages
English (en)
Other versions
GB2106388A (en
Inventor
Akira Hayashi
Tomoyoshi Kondo
Hirotaro Narabayashi
Tomokazu Suzuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of GB2106388A publication Critical patent/GB2106388A/en
Application granted granted Critical
Publication of GB2106388B publication Critical patent/GB2106388B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB08227076A 1981-09-22 1982-09-22 Antiparkinsonian agent Expired GB2106388B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56150082A JPS5852219A (ja) 1981-09-22 1981-09-22 パ−キンソン病治療剤

Publications (2)

Publication Number Publication Date
GB2106388A GB2106388A (en) 1983-04-13
GB2106388B true GB2106388B (en) 1986-03-26

Family

ID=15489114

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08227076A Expired GB2106388B (en) 1981-09-22 1982-09-22 Antiparkinsonian agent

Country Status (13)

Country Link
US (1) US4497826A (enExample)
JP (1) JPS5852219A (enExample)
AU (2) AU556542B2 (enExample)
BE (1) BE894451A (enExample)
CA (1) CA1184501A (enExample)
CH (1) CH650926A5 (enExample)
DE (1) DE3235093A1 (enExample)
FR (1) FR2513117B1 (enExample)
GB (1) GB2106388B (enExample)
IT (1) IT1212668B (enExample)
NL (1) NL189648C (enExample)
NZ (1) NZ201864A (enExample)
SE (1) SE462781B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6067420A (ja) * 1983-09-22 1985-04-17 Sumitomo Chem Co Ltd 精神運動興奮抑制剤
NZ209514A (en) * 1983-09-22 1988-03-30 Sumitomo Chemical Co Pharmaceutical compositions containing erythro-3,4-dihydroxyphenylserine and a decarboxylase inhibitor
AU575849B2 (en) * 1983-09-22 1988-08-11 Sumitomo Chemical Company, Limited Pharmaceutical composition and method for treatment of psychomotor excitement
JPS60132935A (ja) * 1983-12-20 1985-07-16 Sumitomo Chem Co Ltd フエニルセリン誘導体及びその製造方法
JPS6185318A (ja) * 1984-10-04 1986-04-30 Sumitomo Seiyaku Kk 利尿薬
ZA889189B (en) * 1986-06-16 1989-08-30 Merck & Co Inc Controlled release combination of carbidopa/levodopa
US4832957A (en) * 1987-12-11 1989-05-23 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
US4983400A (en) * 1986-06-16 1991-01-08 Merck & Co., Inc. Controlled release combination of carbidopa/levodopa
US4863962A (en) * 1988-03-02 1989-09-05 Fidia-Georgetown Institute For The Neurosciences D-DOPA, pharmaceutically acceptable salts thereof, and methods of treating Parkinson's disease
PT99864B (pt) * 1990-12-21 1999-06-30 Schering Ag Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
DE4101873C2 (de) * 1991-01-23 1993-12-09 Isis Pharma Gmbh Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
JP3559572B2 (ja) 1993-01-29 2004-09-02 住友製薬株式会社 急性痛および慢性痛用鎮痛剤
JP3764179B2 (ja) * 1994-07-05 2006-04-05 克寛 西野 運動・意識または言語障害の機能改善剤
US5668114A (en) * 1996-05-08 1997-09-16 Birkmayer Pharmaceuticals NADH and NADPH pharmaceuticals for treating hypertension
GB2348371B (en) * 2000-03-14 2001-04-04 Soares Da Silva Patricio Compositions comprising blockers of L-DOPA renal cell transfer for the treatment of Parkinson's disease
US8158149B2 (en) * 2004-05-12 2012-04-17 Chelsea Therapeutics, Inc. Threo-DOPS controlled release formulation
WO2004100929A1 (en) 2003-05-12 2004-11-25 Synergia Pharma, Inc. Threo-dops controlled release formulation
WO2005025561A1 (en) * 2003-09-04 2005-03-24 Synergia Pharma, Inc. Compositions and methods for orthostatic intolerance
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
US7786126B2 (en) * 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
DK1948155T3 (da) * 2006-06-28 2012-07-02 Chelsea Therapeutics Inc Farmaceutiske præparater omfattende droxidopa
ES2480966T3 (es) * 2007-03-09 2014-07-29 Chelsea Therapeutics, Inc. Droxidopa y composición farmacéutica de la misma para el tratamiento de la fibromialgia
AU2008248382B2 (en) * 2007-05-07 2013-07-18 Chelsea Therapeutics, Inc. Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders
US8580776B2 (en) * 2007-07-10 2013-11-12 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating neurodegenerating diseases
EP2450343A4 (en) 2009-07-01 2013-01-09 Dainippon Sumitomo Pharma Co PROCESS FOR PREPARING THREO-3- (3,4-DIHYDROXYPHENYL) L-SERIN
JP5880913B2 (ja) 2011-05-17 2016-03-09 三郎 佐古田 パーキンソン病の体幹症状（姿勢反射異常）の治療剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE34275B1 (en) * 1969-06-18 1975-03-19 Merck & Co Inc Alpha-hydrazino acids
US3658968A (en) * 1970-06-11 1972-04-25 Merck & Co Inc Composition and method of treatment
DE2305209A1 (de) * 1972-02-14 1973-08-23 Hoffmann La Roche Pharmazeutisches praeparat
AU6889274A (en) * 1973-05-17 1975-11-20 Astra Laekemedel Ab Treatment of neurological disorders
CH580059A5 (enExample) * 1973-08-22 1976-09-30 Hoffmann La Roche
US3920728A (en) * 1973-08-22 1975-11-18 Hoffmann La Roche Separation and resolution of isomeric forms of 3-(3,4-dihydroxy-phenyl)-serine
JPS52125630A (en) * 1976-04-14 1977-10-21 Kyowa Hakko Kogyo Co Ltd Antiperkinson drugs containing l-threo-3,4-dihydroxyphenylserine
JPS56104815A (en) * 1980-01-23 1981-08-20 Sumitomo Chem Co Ltd Remedy for peripheral orthostatic hypotension

Also Published As

Publication number Publication date
CA1184501A (en) 1985-03-26
NZ201864A (en) 1985-12-13
JPH0216284B2 (enExample) 1990-04-16
AU8857882A (en) 1983-03-31
NL189648C (nl) 1993-06-16
BE894451A (fr) 1983-03-21
IT1212668B (it) 1989-11-30
SE462781B (sv) 1990-09-03
SE8205404D0 (sv) 1982-09-21
IT8268118A0 (it) 1982-09-21
JPS5852219A (ja) 1983-03-28
FR2513117B1 (fr) 1986-01-24
AU556542B2 (en) 1986-11-06
NL189648B (nl) 1993-01-18
DE3235093C2 (enExample) 1988-12-29
FR2513117A1 (fr) 1983-03-25
DE3235093A1 (de) 1983-04-07
NL8203594A (nl) 1983-04-18
US4497826A (en) 1985-02-05
AU575267B2 (en) 1988-07-21
CH650926A5 (de) 1985-08-30
SE8205404L (sv) 1983-03-23
AU6750187A (en) 1987-04-16
GB2106388A (en) 1983-04-13

Similar Documents

Publication Publication Date Title
GB2106388B (en) Antiparkinsonian agent
EG15906A (en) Water disperible hydrophol tiening agent
CS404882A2 (en) Zpusob vytvareni iontu kovu
JPS56109557A (en) Antiibacterial agent
CS425382A2 (en) Zpusob vyroby derivatu chinolinu
ZA82264B (en) Hexahydro-trans- and tetrahydropyridoindole neutroleptic agents
PL236044A1 (en) Cross
ZA827550B (en) Pest-combating agents
GB2105831B (en) Coiler-furnace combination
DE3260221D1 (en) Antimicrobial agent
PT74352A (en) One use biberon
CS879682A1 (en) Plochy pletaci stroj s klikovym pohonem jehel
JPS57192557A (en) Deodrant treatment agent
CS75982A1 (en) Zarazedlo s brzdnym zarizenim
CS110085A1 (en) Svisla trubka s ciselnym programovym rizenim
CS53182A1 (en) Rezne zarizeni s regulacnim zarizenim vysky rezu
CS34682A1 (en) Zpusob vyroby reagencniho papiru
CS547782A2 (en) Sterac celniho skla
CS713582A1 (en) Zehlici zarizeni
JPS57149892A (en) Whistling agent
CA48858S (en) Bobbypin
CS602983A2 (en) Herbicidni prostredek s prisadou chranici kulturni rostlinu
CS176482A2 (en) Treci spojka s jednostrannym oblozenim
CS760581A1 (en) Zpusob vetrani prostoru s vytapenim odpadnim teplem
CS384581A1 (en) Pohovka s pohyblivymi castmi

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20020921